Compare RGC & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGC | WNEB |
|---|---|---|
| Founded | 2014 | 1853 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 259.2M |
| IPO Year | 2021 | N/A |
| Metric | RGC | WNEB |
|---|---|---|
| Price | $24.50 | $12.88 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | ★ 287.2K | 53.7K |
| Earning Date | 10-24-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.17% |
| EPS Growth | N/A | ★ 27.15 |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | ★ $79,080,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.48 |
| P/E Ratio | ★ N/A | $19.60 |
| Revenue Growth | N/A | ★ 9.08 |
| 52 Week Low | $0.09 | $7.63 |
| 52 Week High | $83.60 | $13.95 |
| Indicator | RGC | WNEB |
|---|---|---|
| Relative Strength Index (RSI) | 78.40 | 56.18 |
| Support Level | $16.30 | $13.20 |
| Resistance Level | $18.10 | $13.49 |
| Average True Range (ATR) | 1.92 | 0.33 |
| MACD | 0.98 | -0.05 |
| Stochastic Oscillator | 83.21 | 19.55 |
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.